Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide Microspheres for Preventing Pancreatic Fistula After Distal Pancreatectomy
NCT07479784Phase 3Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Peptides
01
Overview
A Phase 3 trial of octreotide LAR in pancreatic fistula (POPF), sponsored by Zhongshan Hospital, Fudan University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
octreotide LAR
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT07479784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07479784.